| HOME >> BIOLOGY >> TECHNOLOGY |
RALEIGH, N.C., July 30 /PRNewswire/ -- SmartGene, Inc., a provider of novel services for the management and analysis of genetic data, today announced that it has entered into an agreement under which The Johns Hopkins Hospital will utilize SmartGene's advanced technology and integrated Web-based services to support more rapid and precise identification of bacterial and fungal pathogens by sequence analysis.
Some bacteria and fungi do not grow quickly or well enough in culture to support timely, accurate identification using conventional microbiology techniques. For this reason, identification based on gene sequencing is often faster and more reliable. SmartGene's technology facilitates efficient identification, following the sequencing of an organism's DNA, by integrating a number of tasks, including sequence editing, alignment, interpretation, creation of dendrograms and reports. DNA sequences are interrogated using SmartGene's broad, constantly updated reference databases, which take account of newly characterized and emerging pathogens. SmartGene's technology allows its customers to manage and more fully utilize their genetic sequence data over time, completely independent of laboratory instrumentation and reagent systems.
"We are delighted to have such a renowned institution adopting our services," said David Ellis, President of SmartGene, Inc. "We shall certainly benefit from the expertise and guidance of the Hopkins scientists, as we evolve our services in microbiology and beyond."
About SmartGene, Inc.
SmartGene, Inc. is the North American subsidiary of SmartGene GmbH, a privately-held company based in Zug, Switzerland, which provides its services worldwide. SmartGene provides web-based suites of functionality to facilitate sequence-based analysis for a variety of clinical, medical research, and veterinary applications. Constant updates to reference data and interpretive algorithms keep SmartGene's customers in step with evolving science and improve the accuracy of sequence interpretation. SmartGene's integrated services increase the speed to result for sequence-based diagnostics and improve workflow in the laboratory. Current modules from SmartGene include Bacteria, Fungi, HIV, HCV, MLST, Influenza, and HLA typing. Future applications will address human genetics as well as food and environmental pathogens. Discover more at www.smartgene.com.
'/>"/>
| SOURCE SmartGene, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
2. Pharsight Expands Strategic Consulting Services Team
3. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
4. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
5. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
6. MINAM Industrial Management Board and New Services
7. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
8. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
9. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
10. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
11. One of Nations Oldest Blood Services Providers Turns to Sysmex America
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |